Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.

Bibliografski detalji
Glavni autor:	Das, Reshita
Daljnji autori:	Omer, Humair Bin MD
Format:	Disertacija
Jezik:	English
Izdano:	Brac University 2024
Teme:	Molecular docking NSCLC 5GPG Structure-based drug design Lung cancer Pharmaceutical chemistry. Biomolecules > Structure. Drugs > Design. Lungs > Cancer.
Online pristup:	http://hdl.handle.net/10361/23926

Similar Items

Molecules associated with the development of lung cancer
od: Rahman, Adree, i dr.
Izdano: (2023)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
od: Hoque, Ismoth Ara
Izdano: (2024)

A review on principles of molecular docking and its application in drug discovery
od: Sharif Ezzaz, Ahamed
Izdano: (2024)

A review on recent advances in drugs for lung cancer treatment
od: Noor, Fouzia
Izdano: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
od: Flora, Sanzida Alam
Izdano: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
od: Jeba, Joynob
Izdano: (2017)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
od: Zangmo, Thinley
Izdano: (2024)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
od: Rahman, Tasnim
Izdano: (2024)

A review on targeted therapies for lung cancer
od: Ashraf, Anushey
Izdano: (2023)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
od: Razna, Amrin Islam
Izdano: (2019)

Potential of liposomes for the treatment of lung cancer- a review
od: Mim, Shanzida
Izdano: (2023)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
od: Paul, Pulock
Izdano: (2024)

Targeting DHFR in breast cancer: exploring expression patterns and identifying potential inhibitors through docking studies
od: Araf, Faiaz Fahim
Izdano: (2024)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
od: Tania, Umme
Izdano: (2023)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
od: Karim, Samia Binte
Izdano: (2024)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
od: Pial, Sazia Afrin
Izdano: (2018)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
od: Shabnam, Musharrat
Izdano: (2018)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
od: Bristy, Israt Zerin
Izdano: (2021)

Immunotherapy in the Management of Lung Cancer
od: Tasnim, Humayra
Izdano: (2022)

Use of combination of satins as antagonists of SPARC in stomach cancer: an in silico study
od: Rashed, Sadman Sakib Bin
Izdano: (2019)

Lung cancer detection and classification using machine learning
od: Arefin, Mahbubul, i dr.
Izdano: (2023)

Molecular docking of Fluvastatin and Teneligliptin targeting AT1R in hypertension
od: Jahan, Esrat
Izdano: (2020)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
od: Mukti, Roushney Fatima, i dr.
Izdano: (2016)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
od: Nandy, Aditi
Izdano: (2022)

Inhibition of Fibroblast Activation Protein alpha (FAP-α) in Colorectal Cancer
od: Tabassum, Azwada
Izdano: (2021)

The role of cryo-electron microscopy in anticancer drug discovery and development
od: Alam, Jemima
Izdano: (2021)

Oncogenes: new targets in cancer treatment
od: Chowdhury, Waseka Shams
Izdano: (2020)

Breast cancer therapy through Liposomal drug delivery system
od: Ome, Nusrat Jahan
Izdano: (2024)

A comprehensive review on drug repurposing in cancer treatment
od: Sarkar, Onusree
Izdano: (2024)

Role of statins as antagonists of SPARC in gastric cancer
od: Shahmat, Rad
Izdano: (2019)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
od: Raihan, Dilraj
Izdano: (2024)

A review on the recent advancements on nanoparticles drug delivery approaches in anti-cancer treatment
od: Hoque, Syeda Mehren
Izdano: (2024)

Identification of the multi-drug resistant genes in the bacteria isolated from the saliva of smoker oral cancer patients and comparative analysis with smoker normal individuals
od: Hasan, Samir, i dr.
Izdano: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
od: Jahan, Nusrat
Izdano: (2024)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
od: Chakraborty, Anuradha
Izdano: (2024)

A computational approach to find alternative drugs for managing depression
od: Mubashira, Musharrat Shaheed
Izdano: (2022)

The impact of cell penetrating peptides in prospective cancer therapy: a review
od: Nashrah, Zannatul
Izdano: (2023)

A novel vaccine designing approach through analyzing computational tools against pathogenic vibrio cholerae’s outer membrane protein of O1 strain as adjuvant
od: Hossain, Ashraf
Izdano: (2023)

Antihypertensive drugs and risk of cancer: A pharmacovigilance study
od: Rahman, Ahadina
Izdano: (2018)

Investigation of cytotoxic and antibacterial activity of methanol extract of callicarpa macrophylla leaves
od: Mona, Rubaiyat Islam
Izdano: (2017)